MDLifespan

MDLifespan, founded by Dr. Paul Savage, is pioneering health optimization with PlasmaXchange—a provisional patented therapeutic plasma exchange (TPE) protocol designed to remove nearly all toxins from the body. The approach is guided by three pillars: data, disease, and detection. Using advanced diagnostics, MDLifespan assesses toxin levels and tracks biomarker changes throughout personalized PlasmaXchange programs to reduce chronic inflammation and support long-term wellness. The company operates as a Public Benefit Corporation, focusing exclusively on Advanced Serial Therapeutic Plasma Exchange protocols tailored for heart health, cognitive function, immune support, longevity, and whole-body rejuvenation.